amifostine thiol (GR1014)
/ Alys Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 26, 2025
GuARD: A Study of GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer
(clinicaltrials.gov)
- P2 | N=273 | Active, not recruiting | Sponsor: Graegis Pharmaceuticals Ltd
New P2 trial • Breast Cancer • Dermatitis • Dermatology • Immunology • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1